On Thursday, the shareholders of Core Scientific did something unusual. They rejected a $9 billion acquisition offer. Not because the price was too low, but because they believed the company’s pivot from Bitcoin mining to AI infrastructure, fueled by a new partnership with AMD, could unlock more value. The ledger does not lie, only the interpreters do. The interpretation here is clear: the market has set a new valuation floor, and every subsequent move will be measured against that number.
Context: The Infrastructure Alchemist
Core Scientific is not a protocol. It is a physical infrastructure company that operates Bitcoin mining rigs and, increasingly, high-performance computing (HPC) data centers for AI workloads. After emerging from Chapter 11 bankruptcy in early 2024, the company struck a multi-year hosting deal with CoreWeave, a pure-play AI cloud provider. The AMD partnership, announced alongside the shareholder vote, is the next phase: diversifying chip supply beyond NVIDIA and leveraging existing power contracts to host AMD Instinct GPUs.
This is a corporate transformation, not a code upgrade. The core asset is not a smart contract but a portfolio of long-term power purchase agreements (PPAs) secured at below-market rates. These PPAs, originally negotiated for Bitcoin mining, now serve as the economic foundation for GPU hosting. The company’s technical viability hinges on its ability to convert kilowatt-hours into AI compute cycles, not hash power.
Core: The Technical Reality of the AMD Pivot
Based on my audit experience during the 2017 ICO cycle, I learned that press releases are not due diligence. The AMD partnership has been described as a supply agreement, but no technical deliverables have been disclosed. No megawatt commitments, no utilization rates, no test results. The claim that this partnership surpasses the rejected acquisition is a narrative, not a fact.
From a technical standpoint, converting a Bitcoin mining facility into an AI data center is feasible but complex. Mining rigs are air-cooled, low-density, and operate on a simple network. AI clusters require liquid cooling, high-density racks, InfiniBand or RoCE networking, and GPU cluster orchestration. AMD’s ROCm software stack, while improving, still lags NVIDIA’s CUDA in ecosystem maturity, especially for enterprise AI workloads. This is a potential bottleneck that could delay capacity deliveries.
Moreover, the capital expenditure required for this transformation is substantial. Core Scientific will likely need to raise additional equity or debt to fund the GPU acquisition and facility upgrades. The $9 billion valuation floor, set by the rejected offer, implies that shareholders expect management to create at least that much long-term value. But the path to that value is littered with execution risk.
Liquidity dries up when trust evaporates. If Core Scientific fails to deliver on its AI hosting promises, the stock will reprice toward its mining-only fundamentals. The company’s mining revenue is tied to Bitcoin’s price, which, post-halving, has not yet demonstrated a sustained upward trend. The AI pivot is meant to provide a counter-cyclical revenue stream, but it introduces a new set of dependencies: AMD chip supply, software stability, and client adoption.
Contrarian: The Decoupling Thesis That Isn't
The market narrative is that Core Scientific is decoupling from Bitcoin volatility and becoming an AI infrastructure play. This is partially true, but the decoupling is incomplete. The company’s financial health remains tied to Bitcoin’s price through its mining operations, which still constitute a significant portion of revenue. The AI business, while growing, is not yet large enough to offset a prolonged bear market in crypto.
Furthermore, the shift to AI hosting does not eliminate the risk of chip supply concentration. If AMD faces yield issues or supply shortages, Core Scientific’s capacity commitments become unfulfillable. The company is essentially trading one form of commodity risk (Bitcoin hash price) for another (GPU availability). This is not a hedge; it is a rebalancing of risk factors.
Rebalancing is not panic; it is preservation. But preservation requires that the new risk factors are better understood than the old ones. The AMD partnership lacks the transparency that institutional investors require. Without disclosed technical milestones, the market is buying a thesis, not a product.
Takeaway: Positioning for the Next Cycle
Every bull run is a tax on due diligence. The Core Scientific shareholder vote is a bet that the company can execute a complex infrastructure transformation while maintaining financial discipline. The next 12 months will reveal whether the AMD partnership is a genuine catalyst or a marketing distraction. Investors should watch for concrete metrics: delivered MW of AI compute, utilization rates, and ROCm performance benchmarks. Until then, the $9 billion benchmark remains a phantom anchor, pulled by the currents of narrative and speculation.